Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Current approaches for neoadjuvant chemotherapy in breast cancer.

Connolly RM, Stearns V.

Eur J Pharmacol. 2013 Oct 5;717(1-3):58-66. doi: 10.1016/j.ejphar.2013.02.057. Epub 2013 Mar 29. Review.

2.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
3.

When and how do I use neoadjuvant chemotherapy for breast cancer?

Rapoport BL, Demetriou GS, Moodley SD, Benn CA.

Curr Treat Options Oncol. 2014 Mar;15(1):86-98. doi: 10.1007/s11864-013-0266-0. Review.

PMID:
24306808
4.

Current and future roles of neoadjuvant chemotherapy in operable breast cancer.

Kim R, Osaki A, Toge T.

Clin Breast Cancer. 2005 Aug;6(3):223-32; discussion 233-4. Review.

PMID:
16137432
5.

Neoadjuvant chemotherapy for early breast cancer.

Mieog JS, van de Velde CJ.

Expert Opin Pharmacother. 2009 Jun;10(9):1423-34. doi: 10.1517/14656560903002105. Review.

PMID:
19505212
6.
7.

Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?

Freedman OC, Verma S, Clemons MJ.

Cancer Treat Rev. 2005 Feb;31(1):1-17. Epub 2004 Nov 18. Review.

PMID:
15707700
8.

Neoadjuvant endocrine therapy of breast cancer: a surgical perspective.

Dixon JM, Anderson TJ, Miller WR.

Eur J Cancer. 2002 Nov;38(17):2214-21. Review.

PMID:
12441257
9.

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.

Gralow JR, Burstein HJ, Wood W, Hortobagyi GN, Gianni L, von Minckwitz G, Buzdar AU, Smith IE, Symmans WF, Singh B, Winer EP.

J Clin Oncol. 2008 Feb 10;26(5):814-9. doi: 10.1200/JCO.2007.15.3510. Review.

PMID:
18258991
10.

Neoadjuvant systemic therapy and the surgical management of breast cancer.

Waljee JF, Newman LA.

Surg Clin North Am. 2007 Apr;87(2):399-415, ix. Review.

PMID:
17498534
11.

Neoadjuvant induction chemotherapy.

Schwartz G.

Minerva Ginecol. 2005 Jun;57(3):327-48. Review.

PMID:
16166939
12.

New treatment sequence protocol to reconstruct locally advanced breast cancer.

Tansley P, Ramsey K, Wong S, Guerrieri M, Pitcher M, Grinsell D.

ANZ J Surg. 2013 Sep;83(9):630-5. doi: 10.1111/ans.12110. Epub 2013 Mar 15. Review.

PMID:
23496238
13.

Neoadjuvant chemotherapy for operable breast cancer: is this the future?

Mamounas EP.

Clin Breast Cancer. 2003 Apr;4 Suppl 1:S10-9. Review.

PMID:
12756074
14.

Neoadjuvant taxanes in the treatment of non-metastatic breast cancer: a systematic review.

Trudeau M, Sinclair SE, Clemons M; Breast Cancer Disease Site Group.

Cancer Treat Rev. 2005 Jun;31(4):283-302. Review.

PMID:
15916855
15.

Preoperative chemotherapy treatment of breast cancer--a review.

Buzdar AU.

Cancer. 2007 Dec 1;110(11):2394-407. Review.

16.

Lessons from the neoadjuvant setting on how best to choose adjuvant therapies.

von Minckwitz G, Loibl S, Maisch A, Untch M.

Breast. 2011 Oct;20 Suppl 3:S142-5. doi: 10.1016/S0960-9776(11)70312-5. Review.

PMID:
22015282
17.

The role of neoadjuvant chemotherapy in the management of primary breast cancer.

Aigner J, Schneeweiss A, Sohn C, Marmé F.

Minerva Ginecol. 2011 Jun;63(3):261-74. Review.

PMID:
21654611
18.

Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients.

Kong X, Moran MS, Zhang N, Haffty B, Yang Q.

Eur J Cancer. 2011 Sep;47(14):2084-90. doi: 10.1016/j.ejca.2011.06.014. Epub 2011 Jul 5. Review.

PMID:
21737257
19.

Primary (neoadjuvant) chemotherapy with docetaxel in breast cancer.

Gradishar WJ.

Clin Breast Cancer. 2001 Oct;2 Suppl 1:S31-5. Review.

PMID:
11970742
20.

Progress in evaluation of pathologic response to neoadjuvant chemotherapy of breast cancer.

Gebreamlak EP, Tse GM, Niu Y.

Anticancer Agents Med Chem. 2013 Feb;13(2):222-6. Review.

PMID:
22934701
Items per page

Supplemental Content

Write to the Help Desk